Skip to main content
. 2017 Jul 6;19(10):1389–1396. doi: 10.1111/dom.12955

Table 1.

Baseline characteristics at randomization

Characteristic N, FAS Faster aspart + basal (n = 116) Basal (n = 120) Total (N = 236)
Age, years (SD) 57.5 (9.9) 57.4 (8.5) 57.4 (9.2)
Gender, n (%)
Male 55 (47.4) 59 (49.2) 114 (48.3)
Female 61 (52.6) 61 (50.8) 122 (51.7)
BMI, kg/m2 (SD) 30.4 (5.0) 31.1 (4.7) 30.8 (4.8)
Body weight, kg (SD) 82.2 (16.2) 85.1 (17.3) 83.7 (16.8)
Duration of diabetes, years (SD) 10.9* (6.1) 11.8 (7.4) 11.3 (6.3)
HbA1c
% (SD) 7.9 (0.7) 7.9 (0.7) 7.9 (0.7)
mmol/mol (SD) 63.2 (7.6) 63.1 (7.4) 63.1 (7.5)
FPG
mmol/L (SD) 7.4 (2.4) 7.7 (2.9) 7.5 (2.6)
mg/dL (SD) 132.5 (43.5) 138.9 (51.4) 135.7 (47.7)
Basal insulin at baseline n (%) n (%) N (%)
Insulin glargine 76 (65.5) 77 (64.2) 153 (64.8)
Insulin detemir 16 (13.8) 17 (14.2) 33 (14.0)
NPH 24 (20.7) 26 (21.7) 50 (21.2)

Abbreviations: BMI, body mass index; FAS, full analysis set; faster aspart, fast‐acting insulin aspart; FPG, fasting plasma glucose; HbA1c, glycosylated haemoglobin; NPH, neutral protamine Hagedorn. The conversion factor used for glucose between mmol/L and mg/dL was 0.0555.

*n = 115; n = 119. Values for baseline characteristics are arithmetic means, unless stated otherwise.